Cyclodextrins may enhance the user experience of wearing face masks
Frankly saying wearing face masks was one of the most hated, law-enforced measures during the past pandemics. A recently granted
Category: Other industrial use
Special Issue: Cyclodextrin-Based Approach in Biotechnology
A special issue on cyclodextrin based approach in biotechnology to be published in Future Pharmacology (an international, scientific, peer-reviewed, open
β-Cyclodextrin modified TiO2 nanofluids to improve the stability and thermal conductivity of oil-based drilling fluids
The application of oil-based drilling fluids (OBDF) in shale oil and gas horizontal wells and complex deep wells has become
Cyclodextrins to control bacteriophages infection in biotechnology
In the biotechnology industry one of the biggest threats for bacteria-driven bioreactors is the infections caused by enemies of bacteria,
Old but Gold (literally)!
It is widely known that beta cyclodextrin has the best cavity for several drug molecules. But what about noble metals?
Self-Healable and Conductive Hydrogel Coatings Based on Host-Guest Complexation between β-Cyclodextrin and Adamantane
Simultaneously self-healable and conductive materials are desirable because of their lightness, long lifetime, and flexibility. Although supramolecular chemistry has been
Waterproof and durable luminescent textiles with HPBCD for marine rescue
It is presented a new type of large-area, functional luminescent textiles fabricated by electrospinning of polymer@perovskite@cyclodextrin@silane composites using CsPbBr3@hydroxypropyl-β-cyclodextrin (HPβCD)
Green β-cyclodextrin-based corrosion inhibitors
In this review, the fundamental behaviour, importance, developments and innovations of β-CD modified with natural and synthetic polymers, β-CD grafted
Site-selective reactions mediated by molecular containers
In this review, various site-selective reactions mediated by molecular containers are summarized. The emphasis is on those reactions that give
Cyclodextrin containing biocidal banknotes
GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH, a company founded 170 years ago, has filed a patent application on papers with biocidal properties